Mori Arkin was bornon 1952 in Herzliya Pituach, Israel, Israel. Mori Arkin got his start in business in 1972 helping his father run a small Israeli pharmaceutical distribution company. As big drug companies began creating their own distribution arms, Arkin and his father moved into generics manufacturing, renaming the firm Agis Industries. They ran it under that name for two decades and then sold it to American pharmaceutical company Perrigo for $818 million in cash and stock in 2004. Arkin still has a tiny stake (less than 1%) in Perrigo, and he's still bullish on the healthcare sector. He's invested in Israeli hedge fund Sphera Global Healthcare and sits on its investment committee, and he's also poured more than $100 million into 20 pharmaceutical and medical device companies, mostly based in Israel. He's also invested in real estate. Arkin's two sons are involved in the family business; his daughter is serving in the Israel Defense Forces. Arkin is an art history buff and enjoys composing music as a hobby. He and his wife, a sculptor, support art students with scholarships to an art center in Herziliya.
Mori Arkin is a member of Healthcare
💰 Net worth: $1.41 Billion (Updated at 22 June 2018)
Some Mori Arkin images
In 1961, his Father Ziama Arkin founded Agis Industries, an Israeli pharmaceutical importer. Agis grew into a generic pharmaceutical manufacturer, and in 2005, Mori Arkin sold Agis to Perrigo for $390 million.
Mori Arkin is the son of Ziama Arkin, who died in 1972, when Mori was 19. Arkin has a degree in psychology and philosophy from Tel Aviv University.